M&G Investment Management’s Charles River Laboratories CRL Stock Holding History

M&G Investment Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,895	Closed	-$1.26M	–	429
2022 Q2	$1.26M	Buy	5,895 +312	+6%	+$76.2K	0.01%	330
2022 Q1	$1.59M	Buy	5,583 +1,007	+22%	+$311K	﹤0.01%	316
2021 Q4	$1.73M	Buy	+4,576	New	+$1.78M	﹤0.01%	304
2020 Q4	–	Sell	-2,580	Closed	-$583K	–	456
2020 Q3	$583K	Buy	+2,580	New	+$535K	0.01%	348

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

M&G Investment Management's CRL Position: Q3 2022 in Review

M&G Investment Management sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 5,895 shares — an estimated $1.26M sold.

M&G Investment Management first reported a position in CRL in Q3 2020 and held it in 4 quarters. The position peaked at $1.73M in Q4 2021. 582 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

M&G Investment Management reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
M&G Investment Management sold 5,895 Charles River Laboratories shares in Q3 2022, an estimated $1.26M.
M&G Investment Management first reported a position in Charles River Laboratories in Q3 2020 and held it in 4 quarters.
M&G Investment Management's Charles River Laboratories position peaked at $1.73M in Q4 2021.
582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on M&G Investment Management's 13F filing for Q3 2022, filed 1 Nov 2022.